Leadership Team 2013-2014

President

Xiang Yang Yu, Ph. D.

Principal Investigator, Ironwood Pharmaceuticals, Inc. Cambridge, MA

 

Vice Presidents

Zhiyong Yang, Ph. D.

Senior Principal Scientist, Pfizer Inc., Cambridge, MA

Qinglin Che, Ph. D.

Research Scientist, Synta Pharmaceuticals, Inc., Lexington, MA

Sue Ma, M. D.

Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA

 

General Manager

Qingqing Cao, Ph. D.

Sr. Engineer, Becton Dickinson (BD), Bedford, MA

 

Executive Committee Members

Lan Cao

Team Lead, Product Development, Organogenesis Inc., Canton, MA

Steven Du, MD, PhD, MBA

President & CEO, Long Pharmaceuticals

Ellen Fan

Sr. Scientist, Arsenal Medical Inc. Watertown, MA

Kevin Fang, Ph. D.

Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA

Henry Gu, J. D.

Counsel, WilmerHale, Boston, MA

Fred Hu, Ph. D.

Executive Director of Discovery Chemistry Services, ChemPartner, Shanghai, China

Shengfang Jin, Ph. D.

Sr. Director/Biology, Agios Pharmaceuticals, Inc., Cambridge, MA

Jinbo Lee, Ph. D.

President, Sage Partner International Inc., Cambridge, MA

Howard (Hao) Li, Ph. D.

Associate Director, Program Office, Novartis Institutes of Biomedical Research, Inc., Cambridge, MA

Fushuang Liu

Vice President, Wuxi Howfond Biopharma, Co. Ltd., Jiangshu, China

Susan Qu, Ph.D. MBA

Principal Project Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA

Ji Shi

Equity research associate, Cowen & Company, Boston MA

Shallwei Sun

General Manager, Callisyn Biomedical, Inc, North Andover, MA

Ze Tian, Ph. D.

Instructor, Dana Farber Cancer Institute/Harvard Medical School, Boston, MA

Wendy Yang, MBA

Sr. Project Manager, Genzyme Corporation, a division of Sanofi, Waltham, MA

Yikai Wang, Ph. D.

The Broad Institute, Cambridge, MA

Yongzhong Wang, Ph. D.

Deputy General Manager, Kanghong Biotechnology Co. Ltd., Chengdu, China

Yueming Wang, MBA

Deputy General Manager, Tide Pharmaceutical Co. Ltd., Beijing, China

Zhigang Wang, Ph. D.

Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA

Li Xing, Ph. D.

Senior Principal Scientist, Pfizer, Inc. Cambridge, MA

Wei Zhang, Ph. D.

Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA

Weiyi(Wendy) Zhang, Ph. D.

President, Boston Lincoln International, Lincoln, MA

Youxin Zhang, Ph. D.

Senior Consultant, Navigant Consulting, Boston, MA

Liping Zhou, Ph. D.

Principal Scientist, Novartis Institute of BioMedical Research., Cambridge, MA

Zhendong Zhu, Ph. D.

Sr. Principal Investigator, Celgene Avilomics Research, Bedford, MA

 

Board of Directors

Zhihong Chen, Ph. D.; Past President (2011-2012)

Principal Scientist, Eisai Inc., Andover, MA

Chaoyang Dai, Ph. D.; Past president (2010-2011)

Vice President of Operations, Acebright, Inc. Bedford, MA

Jun Han, Ph. D.; Founding President

CEO, SOTA International LLC, Boston, MA

Shiwen Lin, Ph. D.; Chairman of the Board

Associate Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA

Lixin Shen, Ph. D.

President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China

Zhao-Kui Wan, Ph. D.; Past-President (2009-2010)

Sr. Principal Scientist, Pfizer Inc., Cambridge, MA

Yihan Wang, Ph. D.;

Associate Director/Chemistry, ARIAD Pharmaceuticals, Inc., Cambridge, MA

Erxi Wu, Ph. D.

Assistant Prof., North Dakota State University, Fargo, ND

Junjun Wu, Ph. D.; Past President (2007-2009)

CEO,WuXi AllNature Biotech LLC, Jiangsu, China

Philip Zhang, Ph. D., J. D.; Immediate Past President

Co-Founder and Co-Managing Principal, Milstein Zhang & Wu LLC, Newton, MA

 

CABA Legal Council

Fred Gilman

Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA

 

CABA Advisors

Youssef Bennani, Ph. D.

Vice President/Discovery Chemistry, Vertex Pharmaceuticals Inc., Cambridge, MA

Tim Clackson, Ph. D.

President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA

Yuan-Hua Ding, Ph. D.

Senior Director & Head of External R&D Innovation - Asia, Pfizer

Pierre Dodion, M. D., MBA

Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA

Chen Li, Ph. D.

Chief Executive Officer, Hua Medicine, Inc., Shanghai, China

Luke Li, Ph. D.

Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer

Shi Li, Ph. D.

CEO, Zerun Biotechnology, Shanghai, CHINA

Yuanli Liu, Ph. D.

Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health

Dawei Ma , Ph. D.

Professor, Shanghai Institute of Organic Chemistry, Shanghai, China

Tarek Mansour, Ph. D.

EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada

Tse Ping

Chairman, Sino Biopharmaceutical Ltd., Beijing, China

John Piwinski, Ph. D.

Principal, JJPiwinski Pharma Consulting, LLC, New York, NY

Steve Projan, Ph. D.

Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD

Tomi Sawyer, Ph. D.

Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA

Liming Shao, Ph. D.

Senior Director/Medicinal Chemistry, Sepracor Inc., Marlborough, MA

Suvit Thaisrivongs, Ph. D.

Vice President, Pfizer, Inc., Cambridge. MA

Roger Tung, Ph. D.

CEO and President, Concert Pharmaceuticals, Lexington, MA

Yibin Xiang, Ph. D.

Senior Director/Medicinal Chemistry, Genzyme Corporation, Cambridge, MA

Gangfeng Xu, Ph. D.

Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories

Steve Yang, Ph. D.

Head of R&D, Asia & Emerging Markets, AstraZeneca

Howard Yuwen, Ph. D.

Executive Director and Head of North America Regulatory Affairs, Alexion Pharmaceuticals, Inc., Cheshire, CT